|
Comparative double-blind randomized trial of 2 rituximab products in patients with CD20+ diffuse large B-cell lymphoma (DLBCL). |
|
|
Stock and Other Ownership Interests - Dr. Reddy's Laboratories |
Consulting or Advisory Role - Bharat Serums; Emcure; Lupin Pharmaceuticals; Mylan |
Research Funding - Dr. Reddy's Laboratories |
|
|
No Relationships to Disclose |
|
|
Research Funding - Celltrion; Cliantha; Dr. Reddy's Laboratories; Lambda Therapeutic Research |
|
|
No Relationships to Disclose |
|
|
Employment - Dr. Reddy's Laboratories |
Stock and Other Ownership Interests - Dr. Reddy's Laboratories |
|
|
Employment - Dr. Reddy's Laboratories |
Stock and Other Ownership Interests - Dr. Reddy's Laboratories |
Patents, Royalties, Other Intellectual Property - PharmaMar |
|
|
Employment - Dr. Reddy's Laboratories |
Stock and Other Ownership Interests - Dr. Reddy's Laboratories |
|
|
Research Funding - Bayer; Shire |
Travel, Accommodations, Expenses - Dr. Reddy's Laboratories; Emcure; Novo Nordisk; Shire |